NuvaRing Blood Clot Lawsuits on the Rise

NuvaRing Blood Clot Lawsuits on the Rise

January 25, 2012 – A Texas woman has filed a lawsuit against the makers of NuvaRing after allegedly suffering a serious blood clot which she claims was caused by the controversial birth control device. The complaint, which was filed on behalf of Dawn Kregel… Read More »

Actos Bladder Cancer Lawsuits Consolidated in California

Actos Bladder Cancer Lawsuits Consolidated in California

January 11, 2012 – All legal claims filed in California state court involving former Actos users who subsequently developed bladder cancer are now set to be consolidated and coordinated during pretrial proceedings. The California Judicial Counsel named Los Angeles Superior Court Judge Carl J…. Read More »

Topamax Oral Cleft Defect Risk May Hinder Approval of New Diet Drug

Topamax Oral Cleft Defect Risk May Hinder Approval of New Diet Drug

January 4, 2012 – Concerns about the risk of cleft lip and cleft palate birth defects from the maternal use of Topamax (generic: topiramate) during pregnancy may affect the approval status of a newly proposed weight loss medication that combines the anti-epileptic drug with… Read More »

Transvaginal Mesh Sales Drop in 2011

Transvaginal Mesh Sales Drop in 2011

January 3, 2011 – According to the results of a recent marketing study conducted by the Millennium Research Group (MRG), transvaginal mesh manufacturers saw sales fall flat in 2011 amidst controversy surrounding the alleged side effects of the devices. The MRG study found that… Read More »

FDA Calls for New Restrictions on Multaq Use

FDA Calls for New Restrictions on Multaq Use

December 21, 2011 – This week, the U.S. Food & Drug Administration (FDA) issued a safety warning for Sanofi’s popular heart drug Multaq (dronedarone), indicating that it may double the risk of death, stroke and heart problems in patients with permanent atrial fibrillation. The… Read More »

Federal Panel Rejects Plavix MDL Consolidation

Federal Panel Rejects Plavix MDL Consolidation

December 19, 2011 – Last week, a panel of judges denied a motion filed by Bristol-Myers Squibb and Sanofi-Aventis to consolidate all federal Plavix lawsuits for coordinated handling during pre-trial litigation. Individual Plavix injury cases will therefore proceed in various district courts throughout the… Read More »

Motion Filed to Consolidate Wright Conserve Hip Lawsuits

Motion Filed to Consolidate Wright Conserve Hip Lawsuits

December 16, 2011 – Last month, a motion was filed with the U.S. Judicial Panel on Multidistrict Litigation to centralize all federal Wright Conserve metal-on-metal hip replacement legal claims that have been brought on behalf of individuals allegedly injured by the defective devices. To… Read More »

PPI Bone Fracture Lawsuit Filed in California

PPI Bone Fracture Lawsuit Filed in California

December 14, 2011 – Earlier this month, an Arizona woman filed a legal claim against the manufacturers of a number of best-selling proton pump inhibitor (PPI) heartburn drugs including Nexium, Prilosec, Protonix, and Prevacid, claiming that the use of these medications caused her to… Read More »

Chantix Litigation Moving Forward

Chantix Litigation Moving Forward

December 14, 2011 – A conference regarding the status of the federal Chantix litigation that was originally set to take place this Friday has been pushed back to January 20 after legal teams told the Court that discovery proceedings were going smoothly, and that… Read More »

FDA Denies Public Citizen’s Plea to Recall Avandia

FDA Denies Public Citizen’s Plea to Recall Avandia

November 30, 2011 – The U.S. Food & Drug Administration (FDA) has rejected a petition filed by consumer watchdog group Public Citizen to have the controversial diabetes drug Avandia recalled from the market. Public Citizen lashed out in response, suggesting that allowing Avandia to… Read More »